Literature DB >> 1463006

Segregation and manifestations of the mtDNA tRNA(Lys) A-->G(8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome.

N G Larsson1, M H Tulinius, E Holme, A Oldfors, O Andersen, J Wahlström, J Aasly.   

Abstract

We have studied the segregation and manifestations of the tRNA(Lys) A-->G(8344) mutation of mtDNA. Three unrelated patients with myoclonus epilepsy and ragged-red fibers (MERRF) syndrome were investigated, along with 30 of their maternal relatives. Mutated mtDNA was not always found in the offspring of women carrying the tRNA(Lys) mutation. Four women had 10%-33% of mutated mtDNA in lymphocytes, and no mutated mtDNA was found in 7 of their 14 investigated children. The presence of mutated mtDNA was excluded at a level of 3:1,000. Five women had a proportion of 43%-73% mutated mtDNA in lymphocytes, and mutated mtDNA was found in all their 12 investigated children. This suggests that the risk for transmission of mutated mtDNA to the offspring increases if high levels are present in the mother and that, above a threshold level of 35%-40%, it is very likely that transmission will occur to all children. The three patients with MERRF syndrome had, in muscle, both 94%-96% mutated mtDNA and biochemical and histochemical evidence of a respiratory-chain dysfunction. Four relatives had a proportion of 61%-92% mutated mtDNA in muscle, and biochemical measurements showed a normal respiratory-chain function in muscle in all cases. These findings suggest that > 92% of mtDNA with the tRNA(Lys) mutation in muscle is required to cause a respiratory-chain dysfunction that can be detected by biochemical methods. There was a positive correlation between the levels of mtDNA with the tRNA(Lys) mutation in lymphocytes and the levels in muscle, in all nine investigated cases. The levels of mutated mtDNA were higher in muscle than in lymphocytes in all cases. In two of the patients with MERRF syndrome, muscle specimens were obtained at different times. In both cases, biochemical measurements revealed a deteriorating respiratory-chain function, and in one case a progressive increase in the amount of cytochrome c oxidase-deficient muscle fibers was found.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463006      PMCID: PMC1682923     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres.

Authors:  A Oldfors; N G Larsson; E Holme; M Tulinius; B Kadenbach; M Droste
Journal:  J Neurol Sci       Date:  1992-07       Impact factor: 3.181

2.  Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome.

Authors:  N G Larsson; E Holme; B Kristiansson; A Oldfors; M Tulinius
Journal:  Pediatr Res       Date:  1990-08       Impact factor: 3.756

3.  Genetic biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF).

Authors:  P Seibel; F Degoul; G Bonne; N Romero; D François; M Paturneau-Jouas; F Ziegler; B Eymard; M Fardeau; C Marsac
Journal:  J Neurol Sci       Date:  1991-10       Impact factor: 3.181

4.  Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease.

Authors:  D C Wallace; X X Zheng; M T Lott; J M Shoffner; J A Hodge; R I Kelley; C M Epstein; L C Hopkins
Journal:  Cell       Date:  1988-11-18       Impact factor: 41.582

5.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

6.  A common mitochondrial DNA mutation in the t-RNA(Lys) of patients with myoclonus epilepsy associated with ragged-red fibers.

Authors:  M Yoneda; Y Tanno; S Horai; T Ozawa; T Miyatake; S Tsuji
Journal:  Biochem Int       Date:  1990-08

7.  Detection of "deleted" mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome.

Authors:  S Mita; B Schmidt; E A Schon; S DiMauro; E Bonilla
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Mitochondrial genetics: a paradigm for aging and degenerative diseases?

Authors:  D C Wallace
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

9.  A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome.

Authors:  A S Noer; H Sudoyo; P Lertrit; D Thyagarajan; P Utthanaphol; R Kapsa; E Byrne; S Marzuki
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

10.  Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities ): disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature.

Authors:  N Fukuhara; S Tokiguchi; K Shirakawa; T Tsubaki
Journal:  J Neurol Sci       Date:  1980-07       Impact factor: 3.181

View more
  51 in total

1.  The frequency of heteroplasmy in the HVII region of mtDNA differs across tissue types and increases with age.

Authors:  C D Calloway; R L Reynolds; G L Herrin; W W Anderson
Journal:  Am J Hum Genet       Date:  2000-03-17       Impact factor: 11.025

2.  Mitochondrial genetics: principles and practice.

Authors:  J M Shoffner; D C Wallace
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

3.  Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in myoclonus epilepsy and ragged-red fibers (MERRF) syndrome by a multiplex molecular beacon based real-time fluorescence PCR.

Authors:  K Szuhai; J Ouweland; R Dirks; M Lemaître; J Truffert; G Janssen; H Tanke; E Holme; J Maassen; A Raap
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

4.  Myoclonic epilepsy and ragged red fibers (MERRF) syndrome: selective vulnerability of CNS neurons does not correlate with the level of mitochondrial tRNAlys mutation in individual neuronal isolates.

Authors:  L Zhou; A Chomyn; G Attardi; C A Miller
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

5.  A8344G tRNALys mutation associated with recurrent brain stem stroke-like episodes.

Authors:  Ioannis Zaganas; Helen Latsoudis; Eufrosini Papadaki; Pelagia Vorgia; Martha Spilioti; Andreas Plaitakis
Journal:  J Neurol       Date:  2009-02-27       Impact factor: 4.849

6.  The distribution of mitochondrial DNA heteroplasmy due to random genetic drift.

Authors:  Passorn Wonnapinij; Patrick F Chinnery; David C Samuels
Journal:  Am J Hum Genet       Date:  2008-10-30       Impact factor: 11.025

7.  Intracellular heteroplasmy for disease-associated point mutations in mtDNA: implications for disease expression and evidence for mitotic segregation of heteroplasmic units of mtDNA.

Authors:  P M Matthews; R M Brown; K Morten; D Marchington; J Poulton; G Brown
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

8.  Clinical variability associated with the mutation at nucleotide position 8344 of the mitochondrial DNA.

Authors:  Y Campos; M A Martín; J Vaamonde; A Cabello; J Esteban; J Arenas
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 9.  Mitochondrial genetics '98 is the bottleneck cracked?

Authors:  J Poulton; V Macaulay; D R Marchington
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

10.  Fatty acid oxidation in fibroblasts from patients with defects in beta-oxidation and in the respiratory chain.

Authors:  N Venizelos; U von Döbeln; L Hagenfeldt
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.